NCT06873113

BFRT for Subacromial Pain

Recruiting now NA Last updated 8 July 2025

What this trial tests

NA trial testing Active BFRT in Shoulder Pain in 36 participants. Currently enrolling.

Timeline

13 May 2025

Primary endpoint
31 March 2027

31 December 2028

Quick facts

Lead sponsor	University of Florida
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	36
Start date	13 May 2025
Primary completion	31 March 2027
Estimated completion	31 December 2028
Sites	1 location across United States

Drugs / interventions tested

• Active BFRT
• Sham BFRT
• Strengthening Exercises with BFRT
• Skilled Physical Therapy Care

Conditions studied

• Shoulder Pain — all drugs for Shoulder Pain →

Sponsor

University of Florida

Who can join

Adults 18 to 50, any sex, with Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this pilot clinical trial is to learn if blood flow restriction training is safe and feasible in patients with subacromial pain. The main questions the investigators aim to answer are:

* What problems do participants with shoulder pain encounter when training with blood flow restriction?
* Is it feasible to apply blood flow restriction training as part of a physical therapy intervention?
* What are some preliminary effects of blood flow restriction training on the recovery of shoulder function and strength?

The investigators will compare active blood flow restriction training to sham (an inactive procedure designed to mimic the active training as closely as possible).

Participants will:

* Visit the clinic for physical therapy visits and exercise with blood flow restriction training for up to 8 weeks
* Visit the clinic for tests before starting the treatment, during the treatment (4 weeks), and after the end of the treatment (8 and 26 weeks).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.